Trials / Recruiting
RecruitingNCT06605079
Enhancing Palliative Care in ICU
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,040 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to reduce the suffering in intensive care through palliative care consultations.
Detailed description
This project investigates the effectiveness and cost-effectiveness of palliative care consultations in the Intensive care unit. Charité will implement the Working Package 2 "Europe-wide harmonized and recommended palliative care practice for ICU" of the approved HORIZON funding application EPIC, to which this ethics application refers. An accompanying anonymous employee survey (doctors/nurses) is conducted once in the intervention phase and once in the control phase in all study centers (see secondary endpoints 57-68 and 71).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Complex intervention | A complex intervention is carried out in the intensive care unit. This includes: * telemedical consultations by specialized palliative care experts from external institutions for the respective hospital staff * the training of hospital staff in the intensive care unit in basic palliative care and * the use of checklists for the early identification of eligible patients and the structured recording of palliative care needs. The efficacy and cost-effectiveness of the complex intervention will be investigated using a controlled clinical trial in a cluster-randomized controlled design. In addition, as part of the multicenter clinical study in WP 2 staff, patients and relatives will also be surveyed. |
| OTHER | Routine treatment | No complex intervention is established, just routine procedures. |
Timeline
- Start date
- 2024-10-10
- Primary completion
- 2027-05-01
- Completion
- 2027-08-01
- First posted
- 2024-09-20
- Last updated
- 2025-09-30
Locations
31 sites across 5 countries: Czechia, Germany, Greece, Israel, Italy
Source: ClinicalTrials.gov record NCT06605079. Inclusion in this directory is not an endorsement.